Eyewire News: The Podcast

Eyewire News
  • 5.0 (1)
  • Business News
  • Updated Weekly

Eyewire News: The Podcast keeps listeners updated with the latest information in the ophthalmic field, featuring breaking news from press releases, medical journals, vision publications, and other news sources.

  1. 5d ago

    FDA Accepts Nanoscopes's Optogenetic Gene Therapy BLA

    The FDA accepts a biologics license application (BLA) for a first-of-its-kind optogenetic gene therapy for RP; a software upgrade from Heru combines several pretesting assessments into a single guided workflow; and a new FDA-approved overnight orthokeratology lens is launched in the US. Learn more about your ad choices. Visit megaphone.fm/adchoices

  2. Sep 2

    FDA Sets PDUFA Date for Investigational Glaucoma Eye Drop

    The FDA accepts Nicox’s NDA for an investigational glaucoma drop; Bausch + Lomb provides updates on two key investigational therapies for dry eye and ocular surface pain; and Ocugen doses the first patient in a global phase 3 trial of an investigational gene therapy for geographic atrophy (GA). Learn more about your ad choices. Visit megaphone.fm/adchoices

  3. Aug 26

    EyePoint Misses Primary Endpoint in Phase 3 Trial But Sees Promise After Analysis

    Eyepoint Pharmaceuticals releases key phase 3 data for its wet AMD drug Duravyu; Zeiss receives FDA clearance for a cloud- and browser-based data management solution; and the FDA expands Sight Sciences’ indications for the TearCare System for the treatment of MGD. Learn more about your ad choices. Visit megaphone.fm/adchoices

  4. Aug 12

    Three Major Acquisitions Announced in Ophthalmology

    Tarsus Pharmaceuticals enters into a definitive agreement to acquire Alkeus Pharmaceuticals; Harrow acquires dry eye disease nasal spray Tyrvaya from Viatris; and Italy-based Alfasigma enters into a share purchase agreement with Sever Life Sciences to acquire 100% of Nordic Pharma and its subsidiaries. Learn more about your ad choices. Visit megaphone.fm/adchoices

  5. Aug 5

    Biocon Launches Eylea Biosimilar Yesafili

    An interchangeable biosimilar to Eylea is launched in the US; patient enrollment is completed in two global phase 3 clinical trials evaluating Duravyu for diabetic macular edema; and Topcon receives CE mark for a fully automated ultra-widefield retinal slit scanner. Learn more about your ad choices. Visit megaphone.fm/adchoices

  6. Jul 29

    FDA Approves Outlook's Lytenava for Wet AMD

    The CEO of Outlook Therapeutics discusses the FDA approval of wet AMD drug Lytenava; Roche receives a major boost in its efforts to commercialize wet AMD treatment Susvimo in Europe; and Glaukos reaches a milestone in its pivotal clinical study of the Preserflo MicroShunt. Learn more about your ad choices. Visit megaphone.fm/adchoices

  7. Jul 22

    PRIMA Retinal Implant Launched in EU

    A retinal implant system allowing patients with GA to regain some functional central vision vison is approved in Europe; Bausch + Lomb launches a new preloaded IOL delivery system in the US; and we review recent advancements and milestones in the development of novel ophthalmic treatments. Learn more about your ad choices. Visit megaphone.fm/adchoices

  8. Jul 15

    Tarsus Buys Investigational Ocular Antiseptic

    Tarsus acquires the maker of an investigational ocular antiseptic; Alcon and RxSight partner to jointly develop adjustable PCIOLs; and the FDA will hold a meeting to discuss Sydnexis’ investigational low-dose atropine therapy for myopia. Learn more about your ad choices. Visit megaphone.fm/adchoices

See All (107)

About

Eyewire News: The Podcast keeps listeners updated with the latest information in the ophthalmic field, featuring breaking news from press releases, medical journals, vision publications, and other news sources.

Information

  • Creator
    Eyewire News
  • Years Active
    2024 - 2026
  • Episodes
    107
  • Rating
    Clean